Advik Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 0.324 million. Revenue was INR 0.324 million compared to INR 0.048 million a year ago. Net loss was INR 2.75 million compared to INR 37.34 million a year ago. Basic loss per share from continuing operations was INR 0.14 compared to INR 1.95 a year ago. Diluted loss per share from continuing operations was INR 0.14 compared to INR 1.95 a year ago.
For the nine months, sales was INR 0.324 million. Revenue was INR 2.86 million compared to INR 0.133 million a year ago. Net loss was INR 5.66 million compared to INR 42.63 million a year ago. Basic loss per share from continuing operations was INR 0.3 compared to INR 2.23 a year ago. Diluted loss per share from continuing operations was INR 0.3 compared to INR 2.23 a year ago.